These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1605783)

  • 1. Recombinant tissue plasminogen activator (rt-PA).
    Epstein C
    Aust Nurses J; 1992 Mar; 21(8):29-30. PubMed ID: 1605783
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.
    Sane DC; Stump DC; Topol EJ; Sigmon KN; Kereiakes DJ; George BS; Mantell SJ; Macy E; Collen D; Califf RM
    Thromb Haemost; 1991 Mar; 65(3):275-9. PubMed ID: 1904653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care of the patient receiving recombinant tissue plasminogen activator.
    White-Williams C
    J Cardiovasc Nurs; 1989 Nov; 4(1):62-7. PubMed ID: 2513380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct].
    Bleifeld W; Verstraete M; Brower RW; Collen D; Dunning AJ; Lubsen J; Michel PL; Schofer J; Vanhaecke J; Van de Werf F
    Klin Wochenschr; 1988; 66 Suppl 12():86-92. PubMed ID: 3126349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
    Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
    Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator for acute coronary thrombosis.
    Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolysis in myocardial infarction (TIMI): update 1987.
    Mueller HS
    Klin Wochenschr; 1988; 66 Suppl 12():93-101. PubMed ID: 3126350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator.
    Loscalzo J; Braunwald E
    N Engl J Med; 1988 Oct; 319(14):925-31. PubMed ID: 3138537
    [No Abstract]   [Full Text] [Related]  

  • 10. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator.
    Wang CT; Lin FC; Khor GT; Chen CH; Huang P
    Am J Emerg Med; 2012 Jan; 30(1):253.e1-2. PubMed ID: 21109385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.
    Imperadore F; Spagnolli W; Martinelli L; Musuraca G; De Girolamo P; Maines M; Vergara G
    Minerva Cardioangiol; 2003 Aug; 51(4):417-8. PubMed ID: 12900724
    [No Abstract]   [Full Text] [Related]  

  • 13. Combinations of thrombolytic agents in acute myocardial infarction.
    Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
    Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of streptokinase and tissue plasminogen activator on left ventricular function.
    White HD
    Adv Exp Med Biol; 1990; 281():383-7. PubMed ID: 2129375
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant tissue-plasminogen activator (rt-PA) in acute myocardial infarction in the Chinese in Hong Kong.
    Woo KS; Tse KK; Mak YK; Chung HK; Tse CY
    Chin Med J (Engl); 1992 May; 105(5):374-8. PubMed ID: 1499366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the clinical laboratory in monitoring fibrinolytic therapy of acute myocardial infarction.
    Bovill E; Triplett D; Stump D
    Hematol Pathol; 1990; 4(2):61-6. PubMed ID: 2115512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary thrombolysis with tissue-type plasminogen activator: an overview.
    Van de Werf F; Collen D
    Eur Heart J; 1985 Nov; 6(11):902-4. PubMed ID: 3935445
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute myocardial infarction and thrombolytic therapy.
    Yasuda T; Gold HK
    Thromb Res Suppl; 1990; 10():73-9. PubMed ID: 2107600
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction].
    Gao R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.